{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T20:33:08Z","timestamp":1724963588408},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T00:00:00Z","timestamp":1340236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10147-012-0431-7","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T21:55:45Z","timestamp":1340142945000},"page":"641-650","source":"Crossref","is-referenced-by-count":11,"title":["Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances"],"prefix":"10.1007","volume":"18","author":[{"given":"Guo-shun","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu-lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong-ying","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,21]]},"reference":[{"key":"431_CR1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","volume":"118","author":"G Randi","year":"2006","unstructured":"Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118:1591\u20131602","journal-title":"Int J Cancer"},{"key":"431_CR2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.gtc.2010.02.006","volume":"39","author":"S Jayaraman","year":"2010","unstructured":"Jayaraman S, Jarnagin WR (2010) Management of gallbladder cancer. Gastroenterol Clin North Am 39:331\u2013342","journal-title":"Gastroenterol Clin North Am"},{"key":"431_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mrrev.2011.06.002","volume":"728","author":"K Srivastava","year":"2011","unstructured":"Srivastava K, Srivastava A, Sharma KL et al (2011) Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res 728:67\u201379","journal-title":"Mutat Res"},{"key":"431_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.dld.2009.12.008","volume":"42","author":"M Gatto","year":"2010","unstructured":"Gatto M, Bragazzi MC, Semeraro R et al (2010) Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 42:253\u2013260","journal-title":"Dig Liver Dis"},{"key":"431_CR5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.24145","volume":"53","author":"AX Zhu","year":"2011","unstructured":"Zhu AX, Hezel AF (2011) Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities. Hepatology 53:695\u2013704","journal-title":"Hepatology"},{"key":"431_CR6","first-page":"231","volume":"23","author":"S Tucek","year":"2010","unstructured":"Tucek S, Tomasek J, Hal\u00e1mkova J (2010) Bile duct malignancies. Klin Onkol 23:231\u2013241","journal-title":"Klin Onkol"},{"key":"431_CR7","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.3748\/wjg.v12.i21.3425","volume":"12","author":"M Legan","year":"2006","unstructured":"Legan M, Luzar B, Marolt VF et al (2006) Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions. World J Gastroenterol 12:3425\u20133429","journal-title":"World J Gastroenterol"},{"key":"431_CR8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00268-004-7447-8","volume":"28","author":"SC Chuang","year":"2004","unstructured":"Chuang SC, Lee KT, Tsai KB et al (2004) Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers. World J Surg 28:995\u20131000","journal-title":"World J Surg"},{"key":"431_CR9","first-page":"1201","volume":"24","author":"H Puhalla","year":"2004","unstructured":"Puhalla H, Kandioler D, Ludwig C et al (2004) p53 analysis in gallbladder cancer: comparison of gene analysis versus immunohistochemistry. Anticancer Res 24:1201\u20131206","journal-title":"Anticancer Res"},{"key":"431_CR10","first-page":"50","volume":"6","author":"D Kandioler-Eckersberger","year":"2000","unstructured":"Kandioler-Eckersberger D, Ludwig C, Rudas M et al (2000) TP 53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients. Clin Cancer Res 6:50\u201356","journal-title":"Clin Cancer Res"},{"key":"431_CR11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-5223(99)70295-3","volume":"117","author":"D Kandioler-Eckersberger","year":"1999","unstructured":"Kandioler-Eckersberger D, Kappel S, Mittelbock M et al (1999) The TP 53 genotype but not the immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III nonsmall cell lung cancer. J Thorac Cardiovasc Surg 117:744\u2013750","journal-title":"J Thorac Cardiovasc Surg"},{"key":"431_CR12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000658-200204000-00006","volume":"235","author":"D Kandioler","year":"2002","unstructured":"Kandioler D, Zwrtek R, Ludwig C, Janschek E, Ploner M, Hofbauer F et al (2002) TP 53 genotype but not p53 immunohistochemical result predicts response to preoperative short term radiotherapy in rectal cancer. Ann Surg 235:493\u2013498","journal-title":"Ann Surg"},{"key":"431_CR13","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/j.1460-2075.1990.tb08279.x","volume":"9","author":"JV Gannon","year":"1990","unstructured":"Gannon JV, Greaves R, Iggo R et al (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9:1595\u20131602","journal-title":"EMBO J"},{"key":"431_CR14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0908428107","volume":"107","author":"JP Morton","year":"2010","unstructured":"Morton JP, Timpson P, Karim SA et al (2010) Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer. Proc Natl Acad Sci USA 107:246\u2013251","journal-title":"Proc Natl Acad Sci USA"},{"key":"431_CR15","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1158\/1078-0432.CCR-04-1372","volume":"11","author":"R Middelburg","year":"2005","unstructured":"Middelburg R, de Haas RR, Dekker H et al (2005) Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer. Clin Cancer Res 11:1863\u20139186","journal-title":"Clin Cancer Res"},{"key":"431_CR16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1090072","volume":"302","author":"A Villunger","year":"2003","unstructured":"Villunger A, Michalak EM, Coultas L et al (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302:1036\u20131038","journal-title":"Science"},{"key":"431_CR17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1097-2765(01)00213-1","volume":"7","author":"J Yu","year":"2001","unstructured":"Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7:673\u2013682","journal-title":"Mol Cell"},{"key":"431_CR18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","volume":"7","author":"K Nakano","year":"2001","unstructured":"Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683\u2013694","journal-title":"Mol Cell"},{"key":"431_CR19","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/0008-5472.CAN-04-1754","volume":"65","author":"Z Liu","year":"2005","unstructured":"Liu Z, Lu H, Shi H et al (2005) PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res 65:1647\u20135164","journal-title":"Cancer Res"},{"key":"431_CR20","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1074\/jbc.M509868200","volume":"281","author":"J Li","year":"2006","unstructured":"Li J, Lee B, Lee AS (2006) Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J Biol Chem 281:7260\u20137270","journal-title":"J Biol Chem"},{"key":"431_CR21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","volume":"8","author":"EH Cheng","year":"2001","unstructured":"Cheng EH, Wei MC, Weiler S et al (2001) BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8:705\u2013711","journal-title":"Mol Cell"},{"key":"431_CR22","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/sj.onc.1203592","volume":"19","author":"J Hacki","year":"2000","unstructured":"Hacki J, Egger L, Monney L et al (2000) Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene 19:2286\u20132295","journal-title":"Oncogene"},{"key":"431_CR23","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-05-2429","volume":"12","author":"J Yu","year":"2006","unstructured":"Yu J, Yue W, Wu B et al (2006) PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation. Clin Cancer Res 12:2928\u20132936","journal-title":"Clin Cancer Res"},{"key":"431_CR24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.cad.0000231484.17063.9a","volume":"17","author":"F Yu","year":"2006","unstructured":"Yu F, Watts RN, Zhang XD et al (2006) Involvement of BH3-only proapoptotic proteins in mitochondrial-dependent phenoxodiol-induced apoptosis of human melanoma cells. Anticancer Drugs 17:1151\u20131161","journal-title":"Anticancer Drugs"},{"key":"431_CR25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbi.2008.07.012","volume":"176","author":"HF Liu","year":"2008","unstructured":"Liu HF, Hsiao PW, Chao JI (2008) Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells. Chem Biol Interact 176:48\u201357","journal-title":"Chem Biol Interact"},{"key":"431_CR26","doi-asserted-by":"crossref","first-page":"55393","DOI":"10.1074\/jbc.M411658200","volume":"279","author":"J Tanikawa","year":"2004","unstructured":"Tanikawa J, Nomura T, Macmillan EM et al (2004) p53 suppresses c-Myb-induced trans-activation and transformation by recruiting the corepressor mSin3A. J Biol Chem 279:55393\u201355400","journal-title":"J Biol Chem"},{"key":"431_CR27","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1128\/MCB.20.6.1970-1981.2000","volume":"20","author":"M Schmidt","year":"2000","unstructured":"Schmidt M, Nazarov V, Stevens L et al (2000) Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis. Mol Cell Biol 20:1970\u20131981","journal-title":"Mol Cell Biol"},{"key":"431_CR28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0092-8674(00)80401-8","volume":"91","author":"E Kowenz-Leutz","year":"1997","unstructured":"Kowenz-Leutz E, Herr P, Niss K et al (1997) The homeobox gene GBX2, a target of the myb oncogene, mediates autocrine growth and monocyte differentiation. Cell 91:185\u2013195","journal-title":"Cell"},{"key":"431_CR29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.277.5323.246","volume":"277","author":"C Kanei-Ishii","year":"1997","unstructured":"Kanei-Ishii C, Tanikawa J, Nakai A et al (1997) Activation of heat shock transcription factor 3 by c-Myb in the absence of cellular stress. Science 277:246\u2013248","journal-title":"Science"},{"key":"431_CR30","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1038\/sj.onc.1202728","volume":"18","author":"K Weston","year":"1999","unstructured":"Weston K (1999) Reassessing the role of C-MYB in tumorigenesis. Oncogene 18:3034\u20133038","journal-title":"Oncogene"},{"key":"431_CR31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrc2439","volume":"8","author":"RG Ramsay","year":"2008","unstructured":"Ramsay RG, Gonda TJ (2008) MYB function in normal and cancer cells. Nat Rev Cancer 8:523\u2013534","journal-title":"Nat Rev Cancer"},{"key":"431_CR32","first-page":"1991","volume":"56","author":"A Sala","year":"1996","unstructured":"Sala A, Casella I, Grasso L et al (1996) Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53. Cancer Res 56:1991\u20131996","journal-title":"Cancer Res"},{"key":"431_CR33","doi-asserted-by":"crossref","first-page":"15578","DOI":"10.1074\/jbc.M000372200","volume":"275","author":"J Tanikawa","year":"2000","unstructured":"Tanikawa J, Ichikawa-Iwata E, Kanei-Ishii C et al (2000) p53 suppresses the c-Myb-induced activation of heat shock transcription factor 3. J Biol Chem 275:15578\u201315585","journal-title":"J Biol Chem"},{"key":"431_CR34","first-page":"475","volume":"34","author":"H Yamagiwa","year":"1986","unstructured":"Yamagiwa H, Tomiyama H, Yoshimura H (1986) Histogenesis of carcinoma of gallbladder. Histolohical study of serial sections of 1000 cases of resected gallbladder. Rinsho Byori 34:475\u2013480","journal-title":"Rinsho Byori"},{"key":"431_CR35","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/1097-0142(19861015)58:8<1702::AID-CNCR2820580821>3.0.CO;2-Z","volume":"58","author":"GP Dowling","year":"1986","unstructured":"Dowling GP, Kelly JK (1986) The histogenesis of adenocarcinoma of the gallbladder. Cancer 58:1702\u20131708","journal-title":"Cancer"},{"key":"431_CR36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02893485","volume":"13","author":"Y Sanada","year":"2007","unstructured":"Sanada Y, Yoshida K, Ohara M et al (2007) Expression of orotate phosphoribosyltransferase (OPRT) in hepatobiliary and pancreatic carcinoma. Pathol Oncol Res 13:105\u2013113","journal-title":"Pathol Oncol Res"},{"key":"431_CR37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02940312","volume":"13","author":"HJ Chang","year":"2007","unstructured":"Chang HJ, Yoo BC, Kim SW et al (2007) Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas. Pathol Oncol Res 13:326\u2013335","journal-title":"Pathol Oncol Res"},{"key":"431_CR38","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM200110043451414","volume":"345","author":"LH Augenlicht","year":"2001","unstructured":"Augenlicht LH (2001) Clinical response to fluorouracil and p53. N Engl J Med 345:1065","journal-title":"N Engl J Med"},{"key":"431_CR39","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM200104193441603","volume":"344","author":"T Watanabe","year":"2001","unstructured":"Watanabe T, Wu TT, Catalano PJ et al (2001) Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344:1196\u20131206","journal-title":"N Engl J Med"},{"key":"431_CR40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1563-2563.2001.01030.x","volume":"33","author":"H Puhalla","year":"2001","unstructured":"Puhalla H, Wild T, Filipits M et al (2001) Der prognostische Wert der p53 Immunhistochemie beim Gallenblasenkarzinom. Acta Chir Austr 33:85\u201388","journal-title":"Acta Chir Austr"},{"key":"431_CR41","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1072-7515(01)01012-2","volume":"193","author":"ZW Quan","year":"2001","unstructured":"Quan ZW, Wu K, Wang J et al (2001) Association of p53, p16 and vascular endothelial growth factor expressions with the prognosis and metastasis of gallbladder cancer. J Am Coll Surg 193:380\u2013383","journal-title":"J Am Coll Surg"},{"key":"431_CR42","first-page":"774","volume":"22","author":"I Diamantis","year":"1995","unstructured":"Diamantis I, Karamitopoulou E, Perentes E et al (1995) p53 protein immunoreactiviy in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Histopathology 22:774\u2013779","journal-title":"Histopathology"},{"key":"431_CR43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-5223(99)70295-3","volume":"117","author":"D Kandioler-Eckersberger","year":"1999","unstructured":"Kandioler-Eckersberger D, Kappel S, Mittelbock M et al (1999) The TP 53 genotype but not the immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III nonsmall cell lung cancer. J Thorac Cardov Sur 117:744\u2013750","journal-title":"J Thorac Cardov Sur"},{"key":"431_CR44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10495-010-0538-0","volume":"16","author":"RM Ray","year":"2011","unstructured":"Ray RM, Bhattacharya S, Johnson LR (2011) Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1. Apoptosis 16:35\u201344","journal-title":"Apoptosis"},{"key":"431_CR45","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1158\/1078-0432.CCR-07-5202","volume":"14","author":"FA Sinicrope","year":"2008","unstructured":"Sinicrope FA, Rego RL, Okumura K et al (2008) Prognostic impact of bin, puma, and noxa expression in human colon carcinomas. Clin Cancer Res 14:5810\u20135818","journal-title":"Clin Cancer Res"},{"key":"431_CR46","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.onc.1208374","volume":"24","author":"AM Karst","year":"2005","unstructured":"Karst AM, Dai DL, Martinka M et al (2005) PUMA expression is significantly reduced in human cutaneous melanomas. Oncogene 24:1111\u20131116","journal-title":"Oncogene"},{"key":"431_CR47","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1158\/1078-0432.CCR-07-1224","volume":"13","author":"JS Diallo","year":"2007","unstructured":"Diallo JS, Aldejmah A, Mouhim AF et al (2007) NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model. Clin Cancer Res 13:7044\u20137052","journal-title":"Clin Cancer Res"},{"key":"431_CR48","first-page":"1245","volume":"12","author":"A Jansson","year":"2004","unstructured":"Jansson A, Arbman G, Sun XF (2004) mRNA and protein expression of PUMA in sporadic colorectal cancer. Oncol Rep 12:1245\u20131249","journal-title":"Oncol Rep"},{"key":"431_CR49","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2559.2010.03621.x","volume":"57","author":"CM Coutinho-Camillo","year":"2010","unstructured":"Coutinho-Camillo CM, Louren\u00e7o SV, Nishimoto IN et al (2010) Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma. Histopathology 57:304\u2013316","journal-title":"Histopathology"},{"key":"431_CR50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/jsre.2001.6186","volume":"99","author":"J Brabender","year":"2001","unstructured":"Brabender J, Lord RV, Danenberg KD et al (2001) Increased C-myb mRNA expression in Barretts esophagus and Barretts-associated adenocarcinoma. J Surg Res 99:301\u2013306","journal-title":"J Surg Res"},{"key":"431_CR51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1517\/14712598.8.6.713","volume":"8","author":"TJ Gonda","year":"2008","unstructured":"Gonda TJ, Leo P, Ramsay RG (2008) Estrogen and MYB in breast cancer: potential for new therapies. Expert Opin Biol Ther 8:713\u2013717","journal-title":"Expert Opin Biol Ther"},{"key":"431_CR52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13277-009-0003-2","volume":"31","author":"HR Wilkins","year":"2010","unstructured":"Wilkins HR, Doucet K, Duke V et al (2010) Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing C-myb protein, and decreasing transcription of the anti-apoptosis protein bcl-2. Tumor Biol 31:16\u201322","journal-title":"Tumor Biol"},{"key":"431_CR53","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1096\/fj.01-0040com","volume":"15","author":"H Yang","year":"2001","unstructured":"Yang H, Huang ZZ, Wang J et al (2001) The role of C-myb and SP1 in the up-regulation of methionine adenosyl transferase 2A gene expression in human hepatocellular carcinoma. FASEB J 15:1507\u20131516","journal-title":"FASEB J"},{"key":"431_CR54","first-page":"4432","volume":"55","author":"W Narnberg","year":"1995","unstructured":"Narnberg W, Artue M, Nawrath M et al (1995) Human C-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter. Cancer Res 55:4432\u20134437","journal-title":"Cancer Res"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-012-0431-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-012-0431-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-012-0431-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T00:12:46Z","timestamp":1561853566000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-012-0431-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,21]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1007\/s10147-012-0431-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,21]]}}}